Ocata Therapeutics Inc (NASDAQ:OCAT)

6.14
Delayed Data
As of Mar 27
 -0.06 / -0.97%
Today’s Change
4.95
Today|||52-Week Range
12.73
+0.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-54.4M-72.8M-28.5M-31.0M
 
 
 
 
 
Depreciation138.1K67.2K58.6K93.5K
 
 
 
 
 
Total Other Cash Flow45.2M58.6M9.1M11.9M
 
 
 
 
 
Funds From Operations-9.0M-14.1M-19.3M-19.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-256.8K-493.7K-4.7M3.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-8.8M-13.6M-14.6M-22.0M
 
 
 
 
 
 
InvestingCapital Expenditures-207.4K-36.8K-96.3K-671.8K
 
 
 
 
 
Other Investing - Uses-12.6K0.00-15.1K-38.9K
 
 
 
 
Net Cash Flow Investing-220.0K-36.8K-111.4K-710.8K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings7.6M--0.000.00
 
 
Long Term Debt Reduction0.00--0.00-600.0K
 
 
Net Proceeds Stock Sale14.8M10.9M8.9M17.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing22.4M10.9M8.9M17.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash13.4M-2.8M-5.9M-5.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account